Gene · 151306
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The gut-liver-brain axis in alcohol use disorder: The emerging role of bile acid dysregulation. | Behav Brain Res | 2027 | 42763054 | PubTator, text mining | PubMed |
| Mulberry leaf flavonoids alleviate type 2 diabetes by remodeling the gut microbiota-bile acid axis and activating FXR signaling. | J Ethnopharmacol | 2027 | 42503322 | PubTator, text mining | PubMed |
| Decoding dietary fat: molecular sensing, brain integration, and the biology of flavor. | Can J Physiol Pharmacol | 2026 | 42826400 | PubTator, text mining | PubMed |
| Bile acid signaling in health and disease. | Mol Biomed | 2026 | 42825856 | PubTator, text mining | PubMed |
| Gut microbiota-host co-metabolism in hypertriglyceridemia-associated acute pancreatitis: from causality to precision intervention. | Front Immunol | 2026 | 42819668 | PubTator, text mining | PubMed |
| Bile acids as a "new hormone" in aging-related liver disease. | Life Med | 2026 | 42813208 | PubTator, text mining | PubMed |
| The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer. | Pharmacol Res Perspect | 2026 | 42811458 | PubTator, text mining | PubMed |
| Molecular mechanisms of lipid sensing in human cholecystokinin-secreting enteroendocrine cells. | Mol Metab | 2026 | 42805486 | PubTator, text mining | PubMed |
| Microbiota-Mediator-Host Signaling Networks in Metabolic Syndrome: From Mechanistic Insights to Therapeutic Targeting. | Microorganisms | 2026 | 42795448 | PubTator, text mining | PubMed |
| The Gut-Heart Axis in Cardiovascular Disease: Microbial Metabolites, Mediterranean and Traditional Turkish Dietary Patterns, and Personalized Medicine. | Int J Mol Sci | 2026 | 42794738 | PubTator, text mining | PubMed |
| From Dysbiosis to Blood-Brain Barrier Disruption: The Metabolite-Mediated Gut-Brain Axis in Alzheimer's Disease. | Mol Neurobiol | 2026 | 42764315 | PubTator, text mining | PubMed |
| Design, synthesis, and in vitro application of a two-photon fluorescent probe for fluorescent imaging and in vitro biological evaluation of ulcerative colitis. | Bioorg Chem | 2026 | 42753602 | PubTator, text mining | PubMed |
| Gut microbiota modulates nonalcoholic fatty liver disease (NAFLD) progression via regulation of gluconeogenesis: mechanisms and translational research. | Pharmacol Res | 2026 | 42749095 | PubTator, text mining | PubMed |
| Deoxycalyxin A exerts hypoglycemic effects through activating TGR5-induced GLP-1 secretion via TGR5/PKA/MEK/ERK pathway. | Bioorg Chem | 2026 | 42748751 | PubTator, text mining | PubMed |
| Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad. | Front Pharmacol | 2026 | 42707375 | PubTator, text mining | PubMed |
| Ursodeoxycholic acid as a potential cardioprotective agent: molecular mechanisms, experimental evidence, and clinical perspectives. | Front Pharmacol | 2026 | 42694596 | PubTator, text mining | PubMed |
| From metabolites to membrane vesicles: Unifying gut microbial signals in obesity, t2dm, and MASLD. | World J Microbiol Biotechnol | 2026 | 42690471 | PubTator, text mining | PubMed |
| BRD2-Mediated TGR5 destabilization impairs fatty acid oxidation and drives tubular ferroptosis in diabetic kidney injury. | Free Radic Biol Med | 2026 | 42685932 | PubTator, text mining | PubMed |
| Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling. | Front Med (Lausanne) | 2026 | 42683000 | PubTator, text mining | PubMed |
| Decoding the bile acid-mitochondria axis: Implications for disease management and therapeutic opportunities. | Pharmacol Res | 2026 | 42668075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/151306/papers